The mission of the UW CFAR Developmental Core is to support career development of young scientists from a variety of disciplines into research careers related to HIV/AIDS and to foster collaboration among UW CFAR investigators. This mission is articulated through three specific aims, the first of which is to provide research support (New Investigator Awards [NIAs] and Trainee Support Grants) to junior investigators.
The second aim i s to enhance career development, communication among investigators and multidisciplinary research by sponsoring an annual CFAR Symposium.
The third aim i s to provide initial support for HIV/AIDS research in important new research areas (Emerging Opportunity Grants [EOGs]). A Core Director and Associate Director organize the Core's activities. The CFAR Executive Committee, composed of senior scientists with a wide range of HIV/AIDS-related expertise, will serve as the Developmental Core Committee. The Developmental Core collaborates with all other CFAR cores and scientific programs. The Core's awards will be awarded on a competitive basis to applicants from the UW and affiliated institutions (and University of Hawaii for NIAs). Explicit policies and procedures for each type of award and activity, including eligibility criteria, review committee membership, selection criteria, mentorship for NIA recipients, and specific measurable value-added indicators exist for each core activity. Selection of NIA recipients will be based on merit of the proposed research, qualifications and academic potential of the investigator, potential contribution of the research to the HIV/AIDS field, and relevance to UW CFAR. NIA applications from minority investigators and which involve multidisciplinary projects will be encouraged. Recipients of NIAs will each have a CFAR mentor and a Mentoring Committee. Indicators of success for the NIA program include number of applications with fundable scores, number of funded NIAs, accomplishment of NIA goals, adequate progress on annual NIA written reports, resulting publications, future exogenous funding and number of awardees with careers as HIV/AIDS researchers. The CFAR Symposium showcases local HIV/AIDS research, especially that of NIA and EOG recipients and CFARfunded projects. These activities provide value to the UW and national HIV/AIDS research communities by fostering high quality HIV/AIDS research now and in the future. Lay Description: This project will provide support to help young scientists have successful careers as HIV researchers and help UW HIV researchers communicate and work together better. The project will result in more advances in knowledge about many aspects of HIV;this should help to prevent spread of HIV and improve the health of persons with HIV infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-22
Application #
7878027
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
22
Fiscal Year
2009
Total Cost
$1,077,259
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Fredericksen, Rob J; Mayer, Kenneth H; Gibbons, Laura E et al. (2018) Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care. J Gen Intern Med 33:1661-1668
Wilson, Kate S; Wanje, George; Masese, Linnet et al. (2018) A Prospective Cohort Study of Fertility Desire, Unprotected Sex, and Detectable Viral Load in HIV-Positive Female Sex Workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 78:276-282
Ikoma, Minako; Gantt, Soren; Casper, Corey et al. (2018) KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite. PLoS One 13:e0192659
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Gómez, Laurén A; Crowell, Claudia S; Njuguna, Irene et al. (2018) Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children. Pediatr Infect Dis J 37:916-922
Thomson, Kerry A; Dhanireddy, Shireesha; Andrasik, Michele et al. (2018) Fertility desires and preferences for safer conception strategies among people receiving care for HIV at a publicly-funded clinic in Seattle, WA. AIDS Care 30:121-129
Lohman-Payne, Barbara; Gabriel, Benjamin; Park, Sangshin et al. (2018) HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort. Clin Transl Med 7:26
McGrath, Christine J; Singa, Benson; Langat, Agnes et al. (2018) Non-disclosure to male partners and incomplete PMTCT regimens associated with higher risk of mother-to-child HIV transmission: a national survey in Kenya. AIDS Care 30:765-773
Njuguna, Irene N; Wagner, Anjuli D; Omondi, Vincent O et al. (2018) Financial Incentives for Pediatric HIV Testing in Kenya. Pediatr Infect Dis J 37:1142-1144

Showing the most recent 10 out of 1275 publications